The United States 'is leading the world in the use of compulsory licenses, and is hypocritical in voicing indignance when developing countries issue compulsory licenses for essential drugs,' Washington-based Knowledge Ecology International, with its offices in Geneva, has alleged.
Pfizer alleged India has taken steps that call into question the sustainability of foreign investments and the ability to compete fairly.
Lobby group tells USTR it has got assurance from India on compulsory licensing.
The Directorate General of Civil Aviation (DGCA) on Tuesday suspended Air India's Boeing simulator facility in Mumbai after finding certain alleged lapses during a spot check, a DGCA official said. The pilots, who were scheduled to undergo refresher courses at the Mumbai facility, will now not be able to do so.
The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied.The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied.
Under the current administration, political attitudes toward IP seem to have improved.
The panel of representatives from various ministries and chaired by B K Singh, director, department of pharmaceuticals, has suggested the government negotiate prices of patented medicines based on reference prices of such drugs in other countries such as Britain, Canada, France, Australia and New Zealand.
Leader of the Opposition in Rajya Sabha Mallikarjun Kharge on Sunday wrote to Prime Minister Narendra Modi and Rajya Sabha Chairman M Venkaiah Naidu and suggested to convene an all party meeting and virtual meetings of Parliament Standing Committees to discuss the COVID-19 situation in the country.
It was in 2005, India changed its patent law and started granting patents in medicines.
We must resist the temptation to look at the absolute numbers being vaccinated, and focus instead on the percentage of the population vaccinated, he said in his letter.
The transition of Class A and Class B medical device makers to the licensing regime by October 1 seems to be an uphill task with several small and medium manufacturers saying they are still awaiting the audit from the government authorities. If the licenses don't come through, either due to lack of audits or MSME units not clearing the audits, then a few thousand small-scale medical device units will face the issue of business continuity in three weeks. Class A medical devices are those with low to moderate risk to the patient or user (surgical dressings for example), while Class B medical devices refer to devices with moderate risks that require special controls (catheters for example).
India on Thursday approved crucial amendments in the WTO agreement on TRIPS permitting governments to break the monopoly of manufacturers of patented drugs by giving 'compulsory licenses' in emergency situations.
In the first half of this year, 33 pilots and 97 cabin-crew members failed their compulsory alcohol tests, which are conducted either before or after flights, according to data from the Directorate General of Civil Aviation (DGCA). In contrast, in the first half of 2022, the DGCA data recorded only 14 pilots and 54 cabin-crew members being identified as intoxicated while on duty. This data has been reviewed by Business Standard. As per the DGCA rules, pilots and cabin-crew members have to undergo pre-flight breath-analyzer tests.
India is not so keen to co-operate with the US on IPR related probe.
'The vaccine policy should be such that all people should get the vaccine free.'
Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual property.
In a joint letter to the prime minister, the opposition leaders, including some chief ministers, have also demanded providing foodgrains to the needy, and giving Rs 6,000 per month to the unemployed.
Services attracted the most FDI during the first eleven months period of 2015-16.
With an eye on improving quality assurance in the wake of increased global scrutiny on Indian pharma products, the Centre on Tuesday said that Schedule M of the Drugs and Cosmetics Act, 1940 will be made compulsory for small and medium scale manufacturers in a phased manner. Union Health Minister Mansukh Mandaviya has asked micro-small and medium enterprises in pharma manufacturing to move towards good manufacturing practices (GMP) through self regulation. "This will help in quality assurance and also reduce compliance burden," Mandaviya.
Delegation visit ahead of patent law report.
A certain segment of the US pharma industry have become vocal about Indian policies on domestic content requirements and IPR.
DGCA's move seeks to ban perfumes for pilots as they have alcohol and can affect the results of breathanalyser tests. But the FAA and EASA have different standards, says senior journalist Shobha John.
Maharashtra is expecting its active caseload to reach 11.9 lakh by April 30, compared to the current active caseload of 5.64 lakh, Thackeray said.
US said access to affordable health care entails a large number of factors from rates, logistics to insurance reforms.
The unilateral pressure by US administration on India, at the behest of US Business Associations lobby through US International Trade Commission investigations and request to USTR to enlist India under Priority Foreign Country under Special 301 review, lacks legitimacy under WTO framework, the signatories to the letter said.
Failure to recognise the threat of India's IP abuse is a major step back: Congressman Orrin Hatch.
Court has barred generic drugmaker Cipla Ltd from making or selling a cheaper copy of Novartis AG's respiratory drug Onbrez domestically.
In a major liberalisation, the government on Thursday allowed manufacturing of several hundreds of equipment and products in the defence sector without licence.
The Competition Commission has ordered a detailed probe against Google for alleged anti-competitive practices in the smart television operating systems market in the country. After assessing a complaint, the watchdog has reached the prima-facie view that Google is dominant in the relevant market for licensable smart TV device operating systems in India. In a 24-page order, the Competition Commission of India (CCI) said that prima-facie mandatory pre-installation of all the Google applications under TADA amounts to imposition of unfair conditions on the smart TV device manufacturers.
The Supreme Court had rejected the company's plea for a patent on cancer drug Glivec in April.
'Evidently, something has gone terribly wrong in the state of the Indian Union.' 'The rulers seem nervous that the pandemic is spinning out of control,' notes Ambassador M K Bhadrakumar.
These concrete steps should include measures to address any number of pressing concerns, including prohibitively high tariffs and discriminatory forced localization requirements that are blocking US exports of a wide range of products.
Food safety regulator FSSAI has mandated food business operators to mention FSSAI licence or registration number on cash receipts or purchase invoice with effect from October 1 this year. The Food Safety and Standards Authority of India (FSSAI) has issued a latest order in this regard. Since complaints remain unresolved due to lack of specific information, this move will help consumers who can lodge an online complaint against a particular food business using the FSSAI number, it said.
So vaccinate employees and families, staff at home, rickshaw drivers, milkmen, service providers, shopkeepers and street vendors, says Naushad Forbes.
Kerry is scheduled to head to India later this month for the fourth annual US-India Strategic Dialogue.
Multinational organizations including PepsiCo and industry associations like IPA, have come in favour of India's intellectual property regime, which is being reviewed by the US administration.
Hit by the new drug pricing policy and regulatory interventions, growth rate of the Rs 72,069-crore Indian pharmaceutical market has slowed down to 9.8 per cent in 2013 as compared to 16.6 per cent in 2012, says a report.
Seeking to minimise the impact of the recent headline-grabbing moves, he said there had only been one instance of compulsory licensing.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances